Finance

Lists
1RGEN:BIT
Repligen Corp
€152.65
-2.58%
(-4.05) 1D
Aug 24, 3:31:56 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1RGEN...
Mkt. cap
9.95B
Avg. vol.
27.00
Volume
0.00
52-wk high
€156.35
52-wk low
€89.54
No. of employees
2K
Mkt. cap
9.95B
Avg. vol.
27.00
Volume
0.00
52-wk high
€156.35
52-wk low
€89.54
No. of employees
2K
News stories
From web sources and news partners
Profile
Repligen Corporation is an American life sciences company that develops and manufactures products used in biological drug manufacturing. The company is headquartered in Waltham, Massachusetts, and is listed on the Nasdaq under the symbol RGEN. Wikipedia
About Repligen Corp
CEOTony J. Hunt
Employees2K
Founded1981
HeadquartersWaltham, Massachusetts, United States
SectorHealth care
Websiterepligen.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
188.80M
197.91M
194.26M
204.13M
Cost of goods sold
88.29M
94.08M
85.97M
94.09M
Cost of revenue
88.29M
94.08M
85.97M
94.09M
Research and development expenses
14.18M
13.12M
14.46M
14.42M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
73.66M
74.36M
76.54M
76.62M
Operating expense
87.84M
87.48M
90.99M
91.04M
Total operating expenses
176.13M
181.56M
176.96M
185.13M
Operating income
12.68M
16.35M
17.29M
19.00M
Other non operating income
-446.00K
-11.48M
-750.00K
-273.00K
EBT including unusual items
17.11M
19.11M
1.77M
14.15M
EBT excluding unusual items
12.96M
17.59M
16.88M
19.08M
Income tax expense
2.20M
5.83M
-6.56M
9.14M
Effective tax rate
12.86%
30.48%
-370.26%
64.62%
Other operating expenses
-
-
-
-
Net income
14.91M
13.29M
8.33M
5.01M
Net profit margin
7.90%
6.71%
4.29%
2.45%
Earnings per share
0.46
0.49
0.48
0.54
Interest and investment income
6.92M
6.75M
6.34M
6.43M
Interest expense
-5.83M
-5.91M
-6.00M
-6.08M
Net interest expenses
1.09M
842.00K
345.00K
347.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
32.69M
36.30M
37.05M
38.06M
Gain or loss from assets sale
-3.38M
-
13.76M
-103.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps